Cancer antigen 125 (CA125) protein is the most used tumor marker for EOC, used in conjunction with computed tomography (CT) and transvaginal ultrasound in monitoring treatment responses and detecting tumor relapse (5). The gene discussed is MUC16; the disease is neoplasm.